CLGN vs ENLV: Side-by-Side Comparison
Compare CollPlant Biotechnologies Ltd New (CLGN) and Enlivex Therapeutics Ltd (ENLV) side by side: market cap USD 4.91M vs USD 126.26M. Financials, growth and model signals on Bullrun.
| Metric | CLGN | ENLV |
|---|---|---|
| Company | CollPlant Biotechnologies Ltd New | Enlivex Therapeutics Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.91M | USD 126.26M |
| P/E ratio | — | 0.0 |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 2.37M | — |
| Revenue growth YoY | +360.4% | — |
| Net income | USD -11.49M | USD 1.24B |
| Gross margin | 64.8% | — |
| Diluted EPS | -0.94 | 25.48 |